Genetronics Biomedical's (GEB) President And CEO To Present At Wells Fargo's 2005 Healthcare Conference 
10/19/2005 5:12:51 PM

SAN DIEGO--(BUSINESS WIRE)--Feb. 25, 2005--Genetronics Biomedical Corporation (AMEX:GEB), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that Avtar Dhillon, MD, President and CEO, will present a corporate overview on the Company at Wells Fargo Securities' 2005 Healthcare Conference on Tuesday, March 1 at 9:30 a.m. Eastern Standard Time (6:30 a.m. PST). The conference will be held at the St. Regis in New York City from March 1 - 2.